Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Conditions
Interventions
celecoxib
Ibuprofen
+1 more
Locations
1066
United States
Carol M. Johnson MD, LLC
Alabaster, Alabama, United States
Orthopaedics West
Bessemer, Alabama, United States
Central Alabama Research
Birmingham, Alabama, United States
Simon Williamson Clinic/Clinical Research Advantage, Inc.
Birmingham, Alabama, United States
Achieve Clinical Research, LLC
Birmingham, Alabama, United States
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama, United States
Start Date
October 4, 2006
Primary Completion Date
April 12, 2016
Completion Date
April 12, 2016
Last Updated
March 3, 2021
NCT07017686
NCT05038553
NCT05790356
NCT03429426
NCT06028438
NCT06800157
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions